RxDoctor Payments Data

Mara Martinez

Family · San Antonio, TXNPI 1578030714

Payments from drug & device makers

$3,614in general payments, 2019–2025

Across 183 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$604
  • Lilly USA, LLC$533
  • Bayer$317
  • Novo Nordisk$316
  • Esperion Therapeutics, Inc.$249
  • Mannkind Corporation$245
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,50797%
  • Education$1073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,614 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide38$58,152
OzempicSemaglutide23$26,767
FarxigaDapagliflozin Propanediol14$21,932
JardianceEmpagliflozin15$21,453
JanuviaSitagliptin Phosphate15$18,826
EliquisApixaban18$16,851
SymbicortBudesonide/Formoterol Fumarate18$8,027
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,095
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,702
Albuterol Sulfate HfaAlbuterol Sulfate64$2,556
Gabapentin68$1,988
Fluticasone Propionate71$1,891
SynthroidLevothyroxine Sodium21$1,823
Omeprazole65$1,670
Atorvastatin Calcium138$1,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$533$58,15238 claims
AstraZenecaFarxiga, Symbicort$212$29,95832 claims
Novo NordiskOzempic$316$26,76723 claims
Boehringer IngelheimJardiance$98$21,45315 claims
MerckJanuvia$110$18,82615 claims
PfizerEliquis$52$16,85118 claims
AbbVieSynthroid$134$1,82321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.

Other family in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →